Cyberonics Announces Peer-Reviewed Publication Of VNS Therapy® Long-Term Comparative Effectiveness Study In Patients With Refractory Epilepsy

[PR Newswire] – HOUSTON, May 6, 2014 /PRNewswire/ — Cyberonics, Inc. (NASDAQ:CYBX) today announced positive results from the PuLsE (Open Prospective Randomized Long-term Effectiveness) study conducted at 28 sites in … more

View todays social media effects on CYBX

View the latest stocks trending across Twitter. Click to view dashboard

See who Cyberonics is hiring next, click here to view